David Hackett

Summary

Affiliation: Wyeth Research
Country: USA

Publications

  1. ncbi request reprint A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder
    David Hackett
    Wyeth Research, 80 avenue du Général de Gaulle, Paris La Defense, France
    Eur Psychiatry 18:182-7. 2003
  2. ncbi request reprint Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder
    Paolo Meoni
    Wyeth Research, Paris, France
    Depress Anxiety 19:127-32. 2004
  3. ncbi request reprint Estimation of symptom-free days in generalized anxiety disorder
    George J Wan
    Wyeth Research, Collegeville, USA
    Curr Med Res Opin 22:587-91. 2006
  4. ncbi request reprint Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London, UK
    J Psychiatr Res 36:209-17. 2002
  5. ncbi request reprint Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms
    Jonathan R T Davidson
    Department of Psychology Behavioral Sciences, Anxiety and Traumatic Stress Program, Duke University Medicine Center, Durham, North Carolina 27710, USA
    Depress Anxiety 16:4-13. 2002
  6. ncbi request reprint Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder
    R Bruce Lydiard
    Southeast Health Consultants, LLC, Charleston, SC 59407, USA
    J Clin Psychiatry 65:838-44. 2004
  7. ncbi request reprint Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release
    Patrice Boyer
    CNRS UMR 7593, Hopital de la Pitie Salpetriere, 47 Boulevard de l Hopital, 75651 Paris, France
    Eur Psychiatry 19:272-9. 2004
  8. ncbi request reprint Venlafaxine versus placebo in the preventive treatment of recurrent major depression
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London W13 8WH, England, UK
    J Clin Psychiatry 65:328-36. 2004
  9. ncbi request reprint Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies
    Mark H Pollack
    Department of Psychiatry, Anxiety Disorders Program, Massachusetts General Hospital, WAC 812, 15 Parkman Street, Boston, MA 02215, USA
    J Clin Psychopharmacol 23:250-9. 2003
  10. ncbi request reprint Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis
    Stuart A Montgomery
    Imperial College School of Medicine, London, United Kingdom
    J Clin Psychopharmacol 22:561-7. 2002

Detail Information

Publications11

  1. ncbi request reprint A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder
    David Hackett
    Wyeth Research, 80 avenue du Général de Gaulle, Paris La Defense, France
    Eur Psychiatry 18:182-7. 2003
    ..These results reflect the importance of study centre selection in accurately determining efficacy in placebo-controlled trials...
  2. ncbi request reprint Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder
    Paolo Meoni
    Wyeth Research, Paris, France
    Depress Anxiety 19:127-32. 2004
    ....
  3. ncbi request reprint Estimation of symptom-free days in generalized anxiety disorder
    George J Wan
    Wyeth Research, Collegeville, USA
    Curr Med Res Opin 22:587-91. 2006
    ..Here, we evaluate the measurement of treatment effectiveness in terms of the number of symptom-free days (SFDs)...
  4. ncbi request reprint Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London, UK
    J Psychiatr Res 36:209-17. 2002
    ..To characterize the response to the serotonin and norepinephrine reuptake inhibitor, venlafaxine extended release (XR), during the long-term treatment of generalized anxiety disorder...
  5. ncbi request reprint Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms
    Jonathan R T Davidson
    Department of Psychology Behavioral Sciences, Anxiety and Traumatic Stress Program, Duke University Medicine Center, Durham, North Carolina 27710, USA
    Depress Anxiety 16:4-13. 2002
    ....
  6. ncbi request reprint Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder
    R Bruce Lydiard
    Southeast Health Consultants, LLC, Charleston, SC 59407, USA
    J Clin Psychiatry 65:838-44. 2004
    ....
  7. ncbi request reprint Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release
    Patrice Boyer
    CNRS UMR 7593, Hopital de la Pitie Salpetriere, 47 Boulevard de l Hopital, 75651 Paris, France
    Eur Psychiatry 19:272-9. 2004
    ..The benefits of venlafaxine ER treatment of GAD extend beyond that of improvement of anxiety symptoms to a significant improvement in the impairment of functioning that is associated with the illness...
  8. ncbi request reprint Venlafaxine versus placebo in the preventive treatment of recurrent major depression
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London W13 8WH, England, UK
    J Clin Psychiatry 65:328-36. 2004
    ..Long-term efficacy and safety of prophylactic venlafaxine treatment were evaluated in outpatients with recurrent major depression...
  9. ncbi request reprint Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies
    Mark H Pollack
    Department of Psychiatry, Anxiety Disorders Program, Massachusetts General Hospital, WAC 812, 15 Parkman Street, Boston, MA 02215, USA
    J Clin Psychopharmacol 23:250-9. 2003
    ..The strongest trends emerged for history of substance abuse or dependence and symptoms of restlessness, sleep disturbance, and difficulty concentrating...
  10. ncbi request reprint Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis
    Stuart A Montgomery
    Imperial College School of Medicine, London, United Kingdom
    J Clin Psychopharmacol 22:561-7. 2002
    ..Overall, these results demonstrate the clinical effectiveness of venlafaxine XR in the short-term and long-term treatment of GAD...
  11. ncbi request reprint Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials
    Ira R Katz
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Geriatr Soc 50:18-25. 2002
    ....